aluates Reports

$ 0.0

Automative

Global Genital Herpes Treatment Drug Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-2V14715

Global Genital Herpes Treatment Drug Market Research Report 2023

BUY CHAPTERS

Global Genital Herpes Treatment Drug Market Research Report 2025

Code: QYRE-Auto-2V14715

Report

March 2025

Pages:99

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Fresenius Kabi

Avet Pharmaceuticals Inc.

Carlsbad Tech

Glenmark Pharmaceuticals, Inc.

Zydus Pharmaceuticals

Mylan Pharmaceutcials, Inc.

Apotex

Epi Health LLC

AiCuris Anti-infective Cures GmbH

Chimerix

Admedus

Sanofi Pasteur SA.

Maruho

F Hoffmann La Roche Ltd

Novartis

Merck& Co. Inc

GlaxoSmithKline PLC

Genital Herpes Treatment Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Genital Herpes Treatment Drug Market

The global market for Genital Herpes Treatment Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Genital Herpes Treatment Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genital Herpes Treatment Drug.

The Genital Herpes Treatment Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Genital Herpes Treatment Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Genital Herpes Treatment Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Genital Herpes Treatment Drug Market Report

Report Metric	Details
Report Name	Genital Herpes Treatment Drug Market
CAGR	5%
Segment by Type	Acyclovir (Zovirax) Famciclovir (Famvir) Valacyclovir (Valtrex) Others
Segment by Application	Hospital Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Fresenius Kabi, Avet Pharmaceuticals Inc., Carlsbad Tech, Glenmark Pharmaceuticals Inc., Zydus Pharmaceuticals, Mylan Pharmaceutcials Inc., Apotex Inc., Epi Health LLC, AiCuris Anti-infective Cures GmbH, Chimerix, Admedus, Sanofi Pasteur SA, Maruho Co. Ltd., F.Hoffmann-La Roche Ltd., Novartis AG, Merck & Co. Inc., GlaxoSmithKline Plc
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Genital Herpes Treatment Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Genital Herpes Treatment Drug Market report?

Ans: The main players in the Genital Herpes Treatment Drug Market are Fresenius Kabi, Avet Pharmaceuticals Inc., Carlsbad Tech, Glenmark Pharmaceuticals Inc., Zydus Pharmaceuticals, Mylan Pharmaceutcials Inc., Apotex Inc., Epi Health LLC, AiCuris Anti-infective Cures GmbH, Chimerix, Admedus, Sanofi Pasteur SA, Maruho Co. Ltd., F.Hoffmann-La Roche Ltd., Novartis AG, Merck & Co. Inc., GlaxoSmithKline Plc

What are the Application segmentation covered in the Genital Herpes Treatment Drug Market report?

Ans: The Applications covered in the Genital Herpes Treatment Drug Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Genital Herpes Treatment Drug Market report?

Ans: The Types covered in the Genital Herpes Treatment Drug Market report are Acyclovir (Zovirax), Famciclovir (Famvir), Valacyclovir (Valtrex), Others

Recommended Reports

Antiviral Drugs

Gynecologic Diseases

Related Infection Therapies

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Genital Herpes Treatment Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Acyclovir (Zovirax)

1.2.3 Famciclovir (Famvir)

1.2.4 Valacyclovir (Valtrex)

1.2.5 Others

1.3 Market by Application

1.3.1 Global Genital Herpes Treatment Drug Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Genital Herpes Treatment Drug Market Perspective (2020-2031)

2.2 Global Genital Herpes Treatment Drug Growth Trends by Region

2.2.1 Global Genital Herpes Treatment Drug Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Genital Herpes Treatment Drug Historic Market Size by Region (2020-2025)

2.2.3 Genital Herpes Treatment Drug Forecasted Market Size by Region (2026-2031)

2.3 Genital Herpes Treatment Drug Market Dynamics

2.3.1 Genital Herpes Treatment Drug Industry Trends

2.3.2 Genital Herpes Treatment Drug Market Drivers

2.3.3 Genital Herpes Treatment Drug Market Challenges

2.3.4 Genital Herpes Treatment Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Genital Herpes Treatment Drug Players by Revenue

3.1.1 Global Top Genital Herpes Treatment Drug Players by Revenue (2020-2025)

3.1.2 Global Genital Herpes Treatment Drug Revenue Market Share by Players (2020-2025)

3.2 Global Genital Herpes Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Genital Herpes Treatment Drug Revenue

3.4 Global Genital Herpes Treatment Drug Market Concentration Ratio

3.4.1 Global Genital Herpes Treatment Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Genital Herpes Treatment Drug Revenue in 2024

3.5 Global Key Players of Genital Herpes Treatment Drug Head office and Area Served

3.6 Global Key Players of Genital Herpes Treatment Drug, Product and Application

3.7 Global Key Players of Genital Herpes Treatment Drug, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Genital Herpes Treatment Drug Breakdown Data by Type

4.1 Global Genital Herpes Treatment Drug Historic Market Size by Type (2020-2025)

4.2 Global Genital Herpes Treatment Drug Forecasted Market Size by Type (2026-2031)

5 Genital Herpes Treatment Drug Breakdown Data by Application

5.1 Global Genital Herpes Treatment Drug Historic Market Size by Application (2020-2025)

5.2 Global Genital Herpes Treatment Drug Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Genital Herpes Treatment Drug Market Size (2020-2031)

6.2 North America Genital Herpes Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Genital Herpes Treatment Drug Market Size by Country (2020-2025)

6.4 North America Genital Herpes Treatment Drug Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Genital Herpes Treatment Drug Market Size (2020-2031)

7.2 Europe Genital Herpes Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Genital Herpes Treatment Drug Market Size by Country (2020-2025)

7.4 Europe Genital Herpes Treatment Drug Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Genital Herpes Treatment Drug Market Size (2020-2031)

8.2 Asia-Pacific Genital Herpes Treatment Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Genital Herpes Treatment Drug Market Size by Region (2020-2025)

8.4 Asia-Pacific Genital Herpes Treatment Drug Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Genital Herpes Treatment Drug Market Size (2020-2031)

9.2 Latin America Genital Herpes Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Genital Herpes Treatment Drug Market Size by Country (2020-2025)

9.4 Latin America Genital Herpes Treatment Drug Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Genital Herpes Treatment Drug Market Size (2020-2031)

10.2 Middle East & Africa Genital Herpes Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Genital Herpes Treatment Drug Market Size by Country (2020-2025)

10.4 Middle East & Africa Genital Herpes Treatment Drug Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Fresenius Kabi

11.1.1 Fresenius Kabi Company Details

11.1.2 Fresenius Kabi Business Overview

11.1.3 Fresenius Kabi Genital Herpes Treatment Drug Introduction

11.1.4 Fresenius Kabi Revenue in Genital Herpes Treatment Drug Business (2020-2025)

11.1.5 Fresenius Kabi Recent Development

11.2 Avet Pharmaceuticals Inc.

11.2.1 Avet Pharmaceuticals Inc. Company Details

11.2.2 Avet Pharmaceuticals Inc. Business Overview

11.2.3 Avet Pharmaceuticals Inc. Genital Herpes Treatment Drug Introduction

11.2.4 Avet Pharmaceuticals Inc. Revenue in Genital Herpes Treatment Drug Business (2020-2025)

11.2.5 Avet Pharmaceuticals Inc. Recent Development

11.3 Carlsbad Tech

11.3.1 Carlsbad Tech Company Details

11.3.2 Carlsbad Tech Business Overview

11.3.3 Carlsbad Tech Genital Herpes Treatment Drug Introduction

11.3.4 Carlsbad Tech Revenue in Genital Herpes Treatment Drug Business (2020-2025)

11.3.5 Carlsbad Tech Recent Development

11.4 Glenmark Pharmaceuticals Inc.

11.4.1 Glenmark Pharmaceuticals Inc. Company Details

11.4.2 Glenmark Pharmaceuticals Inc. Business Overview

11.4.3 Glenmark Pharmaceuticals Inc. Genital Herpes Treatment Drug Introduction

11.4.4 Glenmark Pharmaceuticals Inc. Revenue in Genital Herpes Treatment Drug Business (2020-2025)

11.4.5 Glenmark Pharmaceuticals Inc. Recent Development

11.5 Zydus Pharmaceuticals

11.5.1 Zydus Pharmaceuticals Company Details

11.5.2 Zydus Pharmaceuticals Business Overview

11.5.3 Zydus Pharmaceuticals Genital Herpes Treatment Drug Introduction

11.5.4 Zydus Pharmaceuticals Revenue in Genital Herpes Treatment Drug Business (2020-2025)

11.5.5 Zydus Pharmaceuticals Recent Development

11.6 Mylan Pharmaceutcials Inc.

11.6.1 Mylan Pharmaceutcials Inc. Company Details

11.6.2 Mylan Pharmaceutcials Inc. Business Overview

11.6.3 Mylan Pharmaceutcials Inc. Genital Herpes Treatment Drug Introduction

11.6.4 Mylan Pharmaceutcials Inc. Revenue in Genital Herpes Treatment Drug Business (2020-2025)

11.6.5 Mylan Pharmaceutcials Inc. Recent Development

11.7 Apotex Inc.

11.7.1 Apotex Inc. Company Details

11.7.2 Apotex Inc. Business Overview

11.7.3 Apotex Inc. Genital Herpes Treatment Drug Introduction

11.7.4 Apotex Inc. Revenue in Genital Herpes Treatment Drug Business (2020-2025)

11.7.5 Apotex Inc. Recent Development

11.8 Epi Health LLC

11.8.1 Epi Health LLC Company Details

11.8.2 Epi Health LLC Business Overview

11.8.3 Epi Health LLC Genital Herpes Treatment Drug Introduction

11.8.4 Epi Health LLC Revenue in Genital Herpes Treatment Drug Business (2020-2025)

11.8.5 Epi Health LLC Recent Development

11.9 AiCuris Anti-infective Cures GmbH

11.9.1 AiCuris Anti-infective Cures GmbH Company Details

11.9.2 AiCuris Anti-infective Cures GmbH Business Overview

11.9.3 AiCuris Anti-infective Cures GmbH Genital Herpes Treatment Drug Introduction

11.9.4 AiCuris Anti-infective Cures GmbH Revenue in Genital Herpes Treatment Drug Business (2020-2025)

11.9.5 AiCuris Anti-infective Cures GmbH Recent Development

11.10 Chimerix

11.10.1 Chimerix Company Details

11.10.2 Chimerix Business Overview

11.10.3 Chimerix Genital Herpes Treatment Drug Introduction

11.10.4 Chimerix Revenue in Genital Herpes Treatment Drug Business (2020-2025)

11.10.5 Chimerix Recent Development

11.11 Admedus

11.11.1 Admedus Company Details

11.11.2 Admedus Business Overview

11.11.3 Admedus Genital Herpes Treatment Drug Introduction

11.11.4 Admedus Revenue in Genital Herpes Treatment Drug Business (2020-2025)

11.11.5 Admedus Recent Development

11.12 Sanofi Pasteur SA

11.12.1 Sanofi Pasteur SA Company Details

11.12.2 Sanofi Pasteur SA Business Overview

11.12.3 Sanofi Pasteur SA Genital Herpes Treatment Drug Introduction

11.12.4 Sanofi Pasteur SA Revenue in Genital Herpes Treatment Drug Business (2020-2025)

11.12.5 Sanofi Pasteur SA Recent Development

11.13 Maruho Co. Ltd.

11.13.1 Maruho Co. Ltd. Company Details

11.13.2 Maruho Co. Ltd. Business Overview

11.13.3 Maruho Co. Ltd. Genital Herpes Treatment Drug Introduction

11.13.4 Maruho Co. Ltd. Revenue in Genital Herpes Treatment Drug Business (2020-2025)

11.13.5 Maruho Co. Ltd. Recent Development

11.14 F.Hoffmann-La Roche Ltd.

11.14.1 F.Hoffmann-La Roche Ltd. Company Details

11.14.2 F.Hoffmann-La Roche Ltd. Business Overview

11.14.3 F.Hoffmann-La Roche Ltd. Genital Herpes Treatment Drug Introduction

11.14.4 F.Hoffmann-La Roche Ltd. Revenue in Genital Herpes Treatment Drug Business (2020-2025)

11.14.5 F.Hoffmann-La Roche Ltd. Recent Development

11.15 Novartis AG

11.15.1 Novartis AG Company Details

11.15.2 Novartis AG Business Overview

11.15.3 Novartis AG Genital Herpes Treatment Drug Introduction

11.15.4 Novartis AG Revenue in Genital Herpes Treatment Drug Business (2020-2025)

11.15.5 Novartis AG Recent Development

11.16 Merck & Co. Inc.

11.16.1 Merck & Co. Inc. Company Details

11.16.2 Merck & Co. Inc. Business Overview

11.16.3 Merck & Co. Inc. Genital Herpes Treatment Drug Introduction

11.16.4 Merck & Co. Inc. Revenue in Genital Herpes Treatment Drug Business (2020-2025)

11.16.5 Merck & Co. Inc. Recent Development

11.17 GlaxoSmithKline Plc

11.17.1 GlaxoSmithKline Plc Company Details

11.17.2 GlaxoSmithKline Plc Business Overview

11.17.3 GlaxoSmithKline Plc Genital Herpes Treatment Drug Introduction

11.17.4 GlaxoSmithKline Plc Revenue in Genital Herpes Treatment Drug Business (2020-2025)

11.17.5 GlaxoSmithKline Plc Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Fresenius Kabi

Avet Pharmaceuticals Inc.

Carlsbad Tech

Glenmark Pharmaceuticals, Inc.

Zydus Pharmaceuticals

Mylan Pharmaceutcials, Inc.

Apotex

Epi Health LLC

AiCuris Anti-infective Cures GmbH

Chimerix

Admedus

Sanofi Pasteur SA.

Maruho

F Hoffmann La Roche Ltd

Novartis

Merck& Co. Inc

GlaxoSmithKline PLC

List of Tables

Table 1. Global Genital Herpes Treatment Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Acyclovir (Zovirax)

Table 3. Key Players of Famciclovir (Famvir)

Table 4. Key Players of Valacyclovir (Valtrex)

Table 5. Key Players of Others

Table 6. Global Genital Herpes Treatment Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Genital Herpes Treatment Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Genital Herpes Treatment Drug Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Genital Herpes Treatment Drug Market Share by Region (2020-2025)

Table 10. Global Genital Herpes Treatment Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Genital Herpes Treatment Drug Market Share by Region (2026-2031)

Table 12. Genital Herpes Treatment Drug Market Trends

Table 13. Genital Herpes Treatment Drug Market Drivers

Table 14. Genital Herpes Treatment Drug Market Challenges

Table 15. Genital Herpes Treatment Drug Market Restraints

Table 16. Global Genital Herpes Treatment Drug Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Genital Herpes Treatment Drug Market Share by Players (2020-2025)

Table 18. Global Top Genital Herpes Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genital Herpes Treatment Drug as of 2024)

Table 19. Ranking of Global Top Genital Herpes Treatment Drug Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Genital Herpes Treatment Drug Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Genital Herpes Treatment Drug, Headquarters and Area Served

Table 22. Global Key Players of Genital Herpes Treatment Drug, Product and Application

Table 23. Global Key Players of Genital Herpes Treatment Drug, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Genital Herpes Treatment Drug Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Genital Herpes Treatment Drug Revenue Market Share by Type (2020-2025)

Table 27. Global Genital Herpes Treatment Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Genital Herpes Treatment Drug Revenue Market Share by Type (2026-2031)

Table 29. Global Genital Herpes Treatment Drug Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Genital Herpes Treatment Drug Revenue Market Share by Application (2020-2025)

Table 31. Global Genital Herpes Treatment Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Genital Herpes Treatment Drug Revenue Market Share by Application (2026-2031)

Table 33. North America Genital Herpes Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Genital Herpes Treatment Drug Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Genital Herpes Treatment Drug Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Genital Herpes Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Genital Herpes Treatment Drug Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Genital Herpes Treatment Drug Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Genital Herpes Treatment Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Genital Herpes Treatment Drug Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Genital Herpes Treatment Drug Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Genital Herpes Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Genital Herpes Treatment Drug Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Genital Herpes Treatment Drug Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Genital Herpes Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Genital Herpes Treatment Drug Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Genital Herpes Treatment Drug Market Size by Country (2026-2031) & (US$ Million)

Table 48. Fresenius Kabi Company Details

Table 49. Fresenius Kabi Business Overview

Table 50. Fresenius Kabi Genital Herpes Treatment Drug Product

Table 51. Fresenius Kabi Revenue in Genital Herpes Treatment Drug Business (2020-2025) & (US$ Million)

Table 52. Fresenius Kabi Recent Development

Table 53. Avet Pharmaceuticals Inc. Company Details

Table 54. Avet Pharmaceuticals Inc. Business Overview

Table 55. Avet Pharmaceuticals Inc. Genital Herpes Treatment Drug Product

Table 56. Avet Pharmaceuticals Inc. Revenue in Genital Herpes Treatment Drug Business (2020-2025) & (US$ Million)

Table 57. Avet Pharmaceuticals Inc. Recent Development

Table 58. Carlsbad Tech Company Details

Table 59. Carlsbad Tech Business Overview

Table 60. Carlsbad Tech Genital Herpes Treatment Drug Product

Table 61. Carlsbad Tech Revenue in Genital Herpes Treatment Drug Business (2020-2025) & (US$ Million)

Table 62. Carlsbad Tech Recent Development

Table 63. Glenmark Pharmaceuticals Inc. Company Details

Table 64. Glenmark Pharmaceuticals Inc. Business Overview

Table 65. Glenmark Pharmaceuticals Inc. Genital Herpes Treatment Drug Product

Table 66. Glenmark Pharmaceuticals Inc. Revenue in Genital Herpes Treatment Drug Business (2020-2025) & (US$ Million)

Table 67. Glenmark Pharmaceuticals Inc. Recent Development

Table 68. Zydus Pharmaceuticals Company Details

Table 69. Zydus Pharmaceuticals Business Overview

Table 70. Zydus Pharmaceuticals Genital Herpes Treatment Drug Product

Table 71. Zydus Pharmaceuticals Revenue in Genital Herpes Treatment Drug Business (2020-2025) & (US$ Million)

Table 72. Zydus Pharmaceuticals Recent Development

Table 73. Mylan Pharmaceutcials Inc. Company Details

Table 74. Mylan Pharmaceutcials Inc. Business Overview

Table 75. Mylan Pharmaceutcials Inc. Genital Herpes Treatment Drug Product

Table 76. Mylan Pharmaceutcials Inc. Revenue in Genital Herpes Treatment Drug Business (2020-2025) & (US$ Million)

Table 77. Mylan Pharmaceutcials Inc. Recent Development

Table 78. Apotex Inc. Company Details

Table 79. Apotex Inc. Business Overview

Table 80. Apotex Inc. Genital Herpes Treatment Drug Product

Table 81. Apotex Inc. Revenue in Genital Herpes Treatment Drug Business (2020-2025) & (US$ Million)

Table 82. Apotex Inc. Recent Development

Table 83. Epi Health LLC Company Details

Table 84. Epi Health LLC Business Overview

Table 85. Epi Health LLC Genital Herpes Treatment Drug Product

Table 86. Epi Health LLC Revenue in Genital Herpes Treatment Drug Business (2020-2025) & (US$ Million)

Table 87. Epi Health LLC Recent Development

Table 88. AiCuris Anti-infective Cures GmbH Company Details

Table 89. AiCuris Anti-infective Cures GmbH Business Overview

Table 90. AiCuris Anti-infective Cures GmbH Genital Herpes Treatment Drug Product

Table 91. AiCuris Anti-infective Cures GmbH Revenue in Genital Herpes Treatment Drug Business (2020-2025) & (US$ Million)

Table 92. AiCuris Anti-infective Cures GmbH Recent Development

Table 93. Chimerix Company Details

Table 94. Chimerix Business Overview

Table 95. Chimerix Genital Herpes Treatment Drug Product

Table 96. Chimerix Revenue in Genital Herpes Treatment Drug Business (2020-2025) & (US$ Million)

Table 97. Chimerix Recent Development

Table 98. Admedus Company Details

Table 99. Admedus Business Overview

Table 100. Admedus Genital Herpes Treatment Drug Product

Table 101. Admedus Revenue in Genital Herpes Treatment Drug Business (2020-2025) & (US$ Million)

Table 102. Admedus Recent Development

Table 103. Sanofi Pasteur SA Company Details

Table 104. Sanofi Pasteur SA Business Overview

Table 105. Sanofi Pasteur SA Genital Herpes Treatment Drug Product

Table 106. Sanofi Pasteur SA Revenue in Genital Herpes Treatment Drug Business (2020-2025) & (US$ Million)

Table 107. Sanofi Pasteur SA Recent Development

Table 108. Maruho Co. Ltd. Company Details

Table 109. Maruho Co. Ltd. Business Overview

Table 110. Maruho Co. Ltd. Genital Herpes Treatment Drug Product

Table 111. Maruho Co. Ltd. Revenue in Genital Herpes Treatment Drug Business (2020-2025) & (US$ Million)

Table 112. Maruho Co. Ltd. Recent Development

Table 113. F.Hoffmann-La Roche Ltd. Company Details

Table 114. F.Hoffmann-La Roche Ltd. Business Overview

Table 115. F.Hoffmann-La Roche Ltd. Genital Herpes Treatment Drug Product

Table 116. F.Hoffmann-La Roche Ltd. Revenue in Genital Herpes Treatment Drug Business (2020-2025) & (US$ Million)

Table 117. F.Hoffmann-La Roche Ltd. Recent Development

Table 118. Novartis AG Company Details

Table 119. Novartis AG Business Overview

Table 120. Novartis AG Genital Herpes Treatment Drug Product

Table 121. Novartis AG Revenue in Genital Herpes Treatment Drug Business (2020-2025) & (US$ Million)

Table 122. Novartis AG Recent Development

Table 123. Merck & Co. Inc. Company Details

Table 124. Merck & Co. Inc. Business Overview

Table 125. Merck & Co. Inc. Genital Herpes Treatment Drug Product

Table 126. Merck & Co. Inc. Revenue in Genital Herpes Treatment Drug Business (2020-2025) & (US$ Million)

Table 127. Merck & Co. Inc. Recent Development

Table 128. GlaxoSmithKline Plc Company Details

Table 129. GlaxoSmithKline Plc Business Overview

Table 130. GlaxoSmithKline Plc Genital Herpes Treatment Drug Product

Table 131. GlaxoSmithKline Plc Revenue in Genital Herpes Treatment Drug Business (2020-2025) & (US$ Million)

Table 132. GlaxoSmithKline Plc Recent Development

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

Table 136. Authors List of This Report

List of Figures

Figure 1. Genital Herpes Treatment Drug Picture

Figure 2. Global Genital Herpes Treatment Drug Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Genital Herpes Treatment Drug Market Share by Type: 2024 VS 2031

Figure 4. Acyclovir (Zovirax) Features

Figure 5. Famciclovir (Famvir) Features

Figure 6. Valacyclovir (Valtrex) Features

Figure 7. Others Features

Figure 8. Global Genital Herpes Treatment Drug Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Genital Herpes Treatment Drug Market Share by Application: 2024 VS 2031

Figure 10. Hospital Case Studies

Figure 11. Clinic Case Studies

Figure 12. Others Case Studies

Figure 13. Genital Herpes Treatment Drug Report Years Considered

Figure 14. Global Genital Herpes Treatment Drug Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Genital Herpes Treatment Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Genital Herpes Treatment Drug Market Share by Region: 2024 VS 2031

Figure 17. Global Genital Herpes Treatment Drug Market Share by Players in 2024

Figure 18. Global Top Genital Herpes Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genital Herpes Treatment Drug as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Genital Herpes Treatment Drug Revenue in 2024

Figure 20. North America Genital Herpes Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Genital Herpes Treatment Drug Market Share by Country (2020-2031)

Figure 22. United States Genital Herpes Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Genital Herpes Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Genital Herpes Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Genital Herpes Treatment Drug Market Share by Country (2020-2031)

Figure 26. Germany Genital Herpes Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Genital Herpes Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Genital Herpes Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Genital Herpes Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Genital Herpes Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Genital Herpes Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Genital Herpes Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Genital Herpes Treatment Drug Market Share by Region (2020-2031)

Figure 34. China Genital Herpes Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Genital Herpes Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Genital Herpes Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Genital Herpes Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Genital Herpes Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Genital Herpes Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Genital Herpes Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Genital Herpes Treatment Drug Market Share by Country (2020-2031)

Figure 42. Mexico Genital Herpes Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Genital Herpes Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Genital Herpes Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Genital Herpes Treatment Drug Market Share by Country (2020-2031)

Figure 46. Turkey Genital Herpes Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Genital Herpes Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Genital Herpes Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Fresenius Kabi Revenue Growth Rate in Genital Herpes Treatment Drug Business (2020-2025)

Figure 50. Avet Pharmaceuticals Inc. Revenue Growth Rate in Genital Herpes Treatment Drug Business (2020-2025)

Figure 51. Carlsbad Tech Revenue Growth Rate in Genital Herpes Treatment Drug Business (2020-2025)

Figure 52. Glenmark Pharmaceuticals Inc. Revenue Growth Rate in Genital Herpes Treatment Drug Business (2020-2025)

Figure 53. Zydus Pharmaceuticals Revenue Growth Rate in Genital Herpes Treatment Drug Business (2020-2025)

Figure 54. Mylan Pharmaceutcials Inc. Revenue Growth Rate in Genital Herpes Treatment Drug Business (2020-2025)

Figure 55. Apotex Inc. Revenue Growth Rate in Genital Herpes Treatment Drug Business (2020-2025)

Figure 56. Epi Health LLC Revenue Growth Rate in Genital Herpes Treatment Drug Business (2020-2025)

Figure 57. AiCuris Anti-infective Cures GmbH Revenue Growth Rate in Genital Herpes Treatment Drug Business (2020-2025)

Figure 58. Chimerix Revenue Growth Rate in Genital Herpes Treatment Drug Business (2020-2025)

Figure 59. Admedus Revenue Growth Rate in Genital Herpes Treatment Drug Business (2020-2025)

Figure 60. Sanofi Pasteur SA Revenue Growth Rate in Genital Herpes Treatment Drug Business (2020-2025)

Figure 61. Maruho Co. Ltd. Revenue Growth Rate in Genital Herpes Treatment Drug Business (2020-2025)

Figure 62. F.Hoffmann-La Roche Ltd. Revenue Growth Rate in Genital Herpes Treatment Drug Business (2020-2025)

Figure 63. Novartis AG Revenue Growth Rate in Genital Herpes Treatment Drug Business (2020-2025)

Figure 64. Merck & Co. Inc. Revenue Growth Rate in Genital Herpes Treatment Drug Business (2020-2025)

Figure 65. GlaxoSmithKline Plc Revenue Growth Rate in Genital Herpes Treatment Drug Business (2020-2025)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Herpes Infection Treatment Market Research Report 2025

Genital Herpes Research and Development Pipeline Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Genital Herpes Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Herpes Labialis Treatment Market Research Report 2024

Global Sexually Transmitted Diseases Drug Market Research Report 2025

Global Herpes Zoste Drug Market Research Report 2025

Global Vaginitis Therapeutics Market Insights Forecast to 2030

Global Human Papillomavirus Infection Drug Market Research Report 2025

Cold Sore Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Epstein Barr Virus HHV 4 Infections Treatment Market Research Report 2024

Global HIV Therapy Drug Market Research Report 2025

Global Gynecological Cancers Drug Market Research Report 2025

Cervical Therapy Apparatus Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Genitourinary System Treatment Market Research Report 2024

Dermatitis Herpetiformis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Human Herpersvirus 5 HHV 5 Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oncolytic Virus Drug Treatment Market Research Report 2025

Global Gynecological Treatment Table Market Research Report 2024

Vaginal and Vulval Inflammatory Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions